You are about to leave Astellas Pharma Australia’s website to access content Astellas is not responsible for.
The information you are being referred to may not comply with the Australian regulatory environment, and you should refer to the relevant
consumer medicine information (CMI) for Astellas products to fully understand the terms of a product’s registration in Australia.
The intent of providing this material is informational and not as advice. Any information provided by this source should be discussed with your healthcare professional, and does not replace their advice.
Products
Health is our passion and priority
Astellas Pharma Australia is focused on providing safe and effective products that improve people's lives. We are committed to making a difference for patients today and providing them with a brighter future tomorrow.
This commitment extends to providing resources for patients and their clinicians and caregivers that help them throughout the life cycle of their condition and beyond.
Downloads of the Product Information (for healthcare professionals) and Consumer Medicine Information (for patients prescribed Astellas products) are available in this section.
Patients should always consult with their healthcare professional for any further information about their specific treatment.
Infectious Disease
Mycamine (micafungin sodium) | Product Information | Consumer Medicine Information
Oncology
Xtandi (enzalutamide) | Product Information | Consumer Medicine Information
Transplantation
Prograf and Advagraf XL (tacrolimus) | Product Information | Consumer Medicine Information
Urology
Betmiga (mirabegron) | Product Information | Consumer Medicine Information
Flomaxtra (tamsulosin hydrochloride) | Product Information | Consumer Medicine Information
Vesicare (solifenacin succinate) | Product Information | Consumer Medicine Information